Discontinuation report ODAN-INDOMETHACIN
| Report ID | 189777 |
| Drug Identification Number | 02231799 |
| Brand name | SANDOZ INDOMETHACIN |
| Common or Proper name | INDOMETHACIN |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | INDOMETHACIN |
| Strength(s) | 50MG |
| Dosage form(s) | SUPPOSITORY |
| Route of administration | RECTAL RECTAL |
| Packaging size | 30SUP |
| ATC code | M01AB |
| ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2023-04-18 |
| Remaining supply date | 2023-04-18 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Sandoz divestment of the following product to Odan in Canada |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2023-04-19 | English | Compare |
| v2 | 2023-04-18 | French | Compare |
| v1 | 2023-04-18 | English | Compare |
Showing 1 to 3 of 3